Beacon Capital Management »

Oramed Pharm shares owned by Beacon Capital Management

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Beacon Capital Management from 13F filings

Historical chart of Beacon Capital Management investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Beacon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Beacon Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $572 219 2.61
2023-09-30 $783 219 3.58
2023-06-30 $783 219 3.58
2023-03-31 $477 219 2.18
2022-12-31 $2.6k 219 12.03

More positions owned by Beacon Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Vanguard Admiral Fds 500 Val Idx Fd (VOOV)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Growth Etf (VUG)
Apple (AAPL)
Vanguard World Fds Inf Tech Etf (VGT)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)

View all positions for Beacon Capital Management

Top funds holding Oramed Pharm

BML Capital Management
Two Sigma Advisers
Bank of America Corporation
Two Sigma Investments
Squarepoint Ops
Jane Street
D. E. Shaw & Co
Citadel Advisors
Jpmorgan Chase & Co
Pnc Financial Services
Assenagon Asset Management
Algert Coldiron Investors
Barclays
N.E.W. Advisory Services
Altshuler Shaham

View all funds holding Oramed Pharm